SYAHRANI, R. A.; LOUISA, M.; WANANDI, S. I. SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS. International Journal of Applied Pharmaceutics, v. 11, n. 6, p. 91-96, 15 Dec. 2019.